Latest Insurance Coverage News

Buru Energy has launched a prospectus offering over 207 million new options free-attaching to a recent $5.3 million placement, aiming to back the commercialisation of its Rafael Gas Project and bolster working capital.

Flight Centre Travel Group has trimmed its FY26 profit forecast due to Middle East conflict impacts on leisure travel, while launching a fresh $200 million share buy-back reflecting confidence in recovery.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.

Whitefield Industrials reported a 5.6% drop in net profit to $21.1 million for FY2026 but maintained its fully franked dividend at 10.5 cents per share, while its portfolio outperformed the ASX200 Industrials benchmark over one and three years.

Brambles has faced a mixed Federal Court ruling in a class action over its FY17 profit guidance, with some claims upheld and others dismissed. The financial impact remains uncertain as the company reviews the judgment and potential appeals.

Aroa Biosurgery has completed its Symphony randomised controlled trial, demonstrating improved healing rates for diabetic foot ulcers compared to standard care. The preliminary results pave the way for clinical adoption and potential US reimbursement.

Straker Ltd announces a pivotal leadership shift with the appointment of David Sowerby and Indiver Nagpal as Co-CEOs, marking a new era focused on commercial expansion and AI innovation. Founder Grant Straker transitions to a strategic board role to steer the company’s AI future.

Neometals Ltd has resolved a longstanding legal dispute with a $1 million settlement, clearing the way to focus on advancing its Barrambie Gold Project and sustainable processing technologies.

FINEOS Corporation Holdings PLC reports a robust €27.8 million cash balance at the end of 2025, maintaining its FY25 revenue guidance despite seasonal cash flow dips and currency fluctuations.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Lumos Diagnostics has achieved a major milestone by securing 100% Medicare reimbursement recognition for its FebriDx test across all seven US Medicare Administrative Contractors, paving the way for broader adoption in the American healthcare system.

Income Asset Management reports a 34% rise in Q1 FY2026 revenue despite uncovering a $3 million fraud involving a former employee, maintaining positive EBITDA and strong client engagement.